haloperidol [SEP] raline on time-based sensitization of cognitive impairment with haloperidol.

Haloperidol [SEP] A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoa


haloperidol [SEP] , randomized, placebo-controlled study evaluated the effects of haloperidol alone and haloperidol plus sertraline on cognitive and psychomo


sertraline [SEP] evaluated the effects of haloperidol alone and haloperidol plus sertraline on cognitive and psychomotor function in 24 healthy male subjec

Sertraline [SEP] A selective serotonin uptake inhibitor that is used in the treatment of depression.


Impairment of cognitive function [SEP] er a 24-hour period after dosing on Days 1, 2, and 25. RESULTS: Impairment of cognitive function was observed 6 to 8 hours after administration of haloperidol o

Cognition Disorders [SEP] Disturbances in the mental process related to thinking, reasoning, and judgment.


Haloperidol [SEP] profiles of sertraline and of placebo were similar. CONCLUSION: Haloperidol produced a clear profile of cognitive impairment that was not w


cognitive impairment [SEP] re similar. CONCLUSION: Haloperidol produced a clear profile of cognitive impairment that was not worsened by concomitant sertraline administration.


Ciprofloxacin [SEP] Ciprofloxacin-induced nephrotoxicity in patients with cancer.

Ciprofloxacin [SEP] A broad-spectrum antimicrobial carboxyfluoroquinoline.


nephrotoxicity [SEP] Ciprofloxacin-induced nephrotoxicity in patients with cancer.

Kidney Diseases [SEP] Pathological processes of the KIDNEY or its component tissues.


cancer [SEP] Ciprofloxacin-induced nephrotoxicity in patients with cancer.

Neoplasms [SEP] New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and me


Nephrotoxicity [SEP] Nephrotoxicity associated with ciprofloxacin is uncommon. Five patients with c


ciprofloxacin [SEP] Nephrotoxicity associated with ciprofloxacin is uncommon. Five patients with cancer who developed acute rena


cancer [SEP] y associated with ciprofloxacin is uncommon. Five patients with cancer who developed acute renal failure that followed treatment with


acute renal failure [SEP] rofloxacin is uncommon. Five patients with cancer who developed acute renal failure that followed treatment with ciprofloxacin are described and an

Acute Kidney Injury [SEP] Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney


creatinine [SEP] d in the literature are reviewed. Other than elevation of serum creatinine levels, characteristic clinical manifestations and abnormal lab

Creatinine [SEP]


interstitial nephritis [SEP] normal laboratory findings are not frequently present. Allergic interstitial nephritis is believed to be the underlying pathological-process. Definiti

Nephritis, Interstitial [SEP] Inflammation of the interstitial tissue of the kidney. This term is generally used for primary inflammation of KIDNEY TUBULES an


pentamidine [SEP] Case report: pentamidine and polymorphic ventricular tachycardia revisited.

Pentamidine [SEP] Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS p


ventricular tachycardia [SEP] Case report: pentamidine and polymorphic ventricular tachycardia revisited.

Tachycardia, Ventricular [SEP] An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the


Pentamidine isethionate [SEP] Pentamidine isethionate has been associated with ventricular tachyarrhythmias, includin


ventricular tachyarrhythmias [SEP] Pentamidine isethionate has been associated with ventricular tachyarrhythmias, including torsade de pointes. This article reports two cases o


torsade de pointes [SEP] as been associated with ventricular tachyarrhythmias, including torsade de pointes. This article reports two cases of this complication and review

Torsades de Pointes [SEP] A malignant form of polymorphic ventricular tachycardia that is characterized by HEART RATE between 200 and 250 beats per minute


Pentamidine [SEP] Pentamidine isethionate has been associated with ventricular tachyarrhythmi


magnesium [SEP]  Pentamidine-induced torsade de pointes may be related to serum magnesium levels and hypomagnesemia may synergistically induce torsade. T

Magnesium [SEP] A metallic element that has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. It is important for the activity of


hypomagnesemia [SEP] torsade de pointes may be related to serum magnesium levels and hypomagnesemia may synergistically induce torsade. Torsade de pointes occurred

Hypomagnesemia primary [SEP]


Torsade de pointes [SEP] m levels and hypomagnesemia may synergistically induce torsade. Torsade de pointes occurred after an average of 10 days of treatment with pentamid


pentamidine [SEP]  pointes occurred after an average of 10 days of treatment with pentamidine. In these patients, no other acute side effects of pentamidine


QTc interval prolongation [SEP] ed early, possibly without discontinuation of pentamidine. When QTc interval prolongation is observed, early magnesium supplementation is advocated.

Long QT Syndrome [SEP] A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by


malondialdehyde [SEP] Time dependence of plasma malondialdehyde, oxypurines, and nucleosides during incomplete cerebral ischemi

Malondialdehyde [SEP] The dialdehyde of malonic acid.


nucleosides [SEP] Time dependence of plasma malondialdehyde, oxypurines, and nucleosides during incomplete cerebral ischemia in the rat.

Nucleosides [SEP] Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed)


cerebral ischemia [SEP]  malondialdehyde, oxypurines, and nucleosides during incomplete cerebral ischemia in the rat.

Brain Ischemia [SEP] Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs


cerebral ischemia [SEP] Incomplete cerebral ischemia (30 min) was induced in the rat by bilaterally clamping the com


ischemia [SEP] Incomplete cerebral ischemia (30 min) was induced in the rat by bilaterally clamping the com

Ischemia [SEP] A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS,


malondialdehyde [SEP] e liquid chromatographic method for the direct determination of malondialdehyde, oxypurines, and nucleosides. During ischemia, a time-dependent


nucleosides [SEP] or the direct determination of malondialdehyde, oxypurines, and nucleosides. During ischemia, a time-dependent increase of plasma oxypurine


acetylsalicylate [SEP] el, one receiving 20 mg/kg b.w. of the cyclooxygenase inhibitor acetylsalicylate intravenously immediately before ischemia, the other receiving

Aspirin [SEP] The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties a


hypotensive [SEP] ore ischemia, the other receiving 650 micrograms/kg b.w. of the hypotensive drug nitroprusside at a flow rate of 103 microliters/min intrav

Hypotension [SEP] Abnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DI


nitroprusside [SEP]  other receiving 650 micrograms/kg b.w. of the hypotensive drug nitroprusside at a flow rate of 103 microliters/min intravenously during isch

Nitroprusside [SEP] A powerful vasodilator used in emergencies to lower blood pressure or to improve cardiac function. It is also an indicator for f


ischemic [SEP] o monitor the metabolic alterations of tissues occurring during ischemic phenomena.(ABSTRACT TRUNCATED AT 250 WORDS)


toxicity [SEP] Cholinergic toxicity resulting from ocular instillation of echothiophate iodide eye

Drug-Related Side Effects and Adverse Reactions [SEP] Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chem


echothiophate iodide [SEP] Cholinergic toxicity resulting from ocular instillation of echothiophate iodide eye drops.

Echothiophate Iodide [SEP] A potent, long-acting cholinesterase inhibitor used as a miotic in the treatment of glaucoma.


echothiophate iodide [SEP] patient developed a severe cholinergic syndrome from the use of echothiophate iodide ophthalmic drops, presented with profound muscle weakness and w


muscle weakness [SEP]  echothiophate iodide ophthalmic drops, presented with profound muscle weakness and was initially given the diagnosis of myasthenia gravis. Red

Muscle Weakness [SEP] A vague complaint of debility, fatigue, or exhaustion attributable to weakness of various muscles. The weakness can be character


myasthenia gravis [SEP] ofound muscle weakness and was initially given the diagnosis of myasthenia gravis. Red blood cell and serum cholinesterase levels were severely d

Myasthenia Gravis [SEP] A disorder of neuromuscular transmission characterized by weakness of cranial and skeletal muscles. Autoantibodies directed agai


Acute renal failure [SEP] Acute renal failure in high dose carboplatin chemotherapy.

Acute Kidney Injury [SEP] Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney


carboplatin [SEP] Acute renal failure in high dose carboplatin chemotherapy.

Carboplatin [SEP] An organoplatinum compound that possesses antineoplastic activity.


Carboplatin [SEP] Carboplatin has been reported to cause acute renal failure when administere


acute renal failure [SEP] Carboplatin has been reported to cause acute renal failure when administered in high doses to adult patients. We report a


carboplatin [SEP]  We report a 4 1/2-year-old girl who was treated with high-dose carboplatin for metastatic parameningeal embryonal rhabdomyosarcoma. Acute


embryonal rhabdomyosarcoma [SEP] treated with high-dose carboplatin for metastatic parameningeal embryonal rhabdomyosarcoma. Acute renal failure developed followed by a slow partial recov

Rhabdomyosarcoma, Embryonal [SEP] A form of RHABDOMYOSARCOMA arising primarily in the head and neck, especially the orbit, of children below the age of 10. The ce


Acute renal failure [SEP] platin for metastatic parameningeal embryonal rhabdomyosarcoma. Acute renal failure developed followed by a slow partial recovery of renal function


Endometrial carcinoma [SEP] Endometrial carcinoma after Hodgkin disease in childhood.

Endometrial Neoplasms [SEP] Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classificati


Hodgkin disease [SEP] Endometrial carcinoma after Hodgkin disease in childhood.

Hodgkin Disease [SEP] A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the cla


endometrial carcinoma [SEP] A 34-year-old patient developed metastic endometrial carcinoma after Hodgkin disease in childhood. She had ovarian failure aft


Hodgkin disease [SEP] year-old patient developed metastic endometrial carcinoma after Hodgkin disease in childhood. She had ovarian failure after abdominal irradiati


ovarian failure [SEP] dometrial carcinoma after Hodgkin disease in childhood. She had ovarian failure after abdominal irradiation and chemotherapy for Hodgkin diseas

Ovarian Diseases [SEP] Pathological processes of the OVARY.


estrogens [SEP] on and chemotherapy for Hodgkin disease, and received exogenous estrogens, a treatment implicated in the development of endometrial cance

Estrogens [SEP] Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estr


endometrial cancer [SEP] ogenous estrogens, a treatment implicated in the development of endometrial cancer in menopausal women. Young women on replacement estrogens for o


cancer [SEP] ogens, a treatment implicated in the development of endometrial cancer in menopausal women. Young women on replacement estrogens for o

Neoplasms [SEP] New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and me


obstructive sleep apnea syndrome [SEP] Induction of the obstructive sleep apnea syndrome in a woman by exogenous androgen administration.

Sleep Apnea, Obstructive [SEP] A disorder characterized by recurrent apneas during sleep despite persistent respiratory efforts. It is due to upper airway obst


androgen [SEP] of the obstructive sleep apnea syndrome in a woman by exogenous androgen administration.

Androgens [SEP] Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. D


syndrome of obstructive sleep apnea [SEP] in a 54-yr-old woman who had developed physical changes and the syndrome of obstructive sleep apnea while being administered exogenous androgens. When the androgen


androgens [SEP] e of obstructive sleep apnea while being administered exogenous androgens. When the androgens were withdrawn, the patient's physical chan


androgen [SEP] e of obstructive sleep apnea while being administered exogenous androgens. When the androgens were withdrawn, the patient's physical cha


obstructive sleep apnea [SEP] ld woman who had developed physical changes and the syndrome of obstructive sleep apnea while being administered exogenous androgens. When the androgen


sleep apnea [SEP]  had developed physical changes and the syndrome of obstructive sleep apnea while being administered exogenous androgens. When the androgen

Sleep Apnea Syndromes [SEP] Disorders characterized by multiple cessations of respirations during sleep that induce partial arousals and interfere with the


obstructive sleep apnea syndrome [SEP] hat predisposes to obstruction during sleep. Development of the obstructive sleep apnea syndrome must be considered a possible side effect of androgen therapy.


captopril [SEP] Effect of captopril on pre-existing and aminonucleoside-induced proteinuria in spon

Captopril [SEP] A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoco


aminonucleoside [SEP] Effect of captopril on pre-existing and aminonucleoside-induced proteinuria in spontaneously hypertensive rats.

Puromycin Aminonucleoside [SEP] PUROMYCIN derivative that lacks the methoxyphenylalanyl group on the amine of the sugar ring. It is an antibiotic with antineopl


proteinuria [SEP] Effect of captopril on pre-existing and aminonucleoside-induced proteinuria in spontaneously hypertensive rats.

Proteinuria [SEP] The presence of proteins in the urine, an indicator of KIDNEY DISEASES.


hypertensive [SEP] isting and aminonucleoside-induced proteinuria in spontaneously hypertensive rats.

Hypertension [SEP] Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is c


Proteinuria [SEP] Proteinuria is a side effect of captopril treatment in hypertensive patient


captopril [SEP] Proteinuria is a side effect of captopril treatment in hypertensive patients. The possibility of reproduc


hypertensive [SEP] Proteinuria is a side effect of captopril treatment in hypertensive patients. The possibility of reproducing the same renal abnorma


renal abnormality [SEP]  hypertensive patients. The possibility of reproducing the same renal abnormality with captopril was examined in SHR. Oral administration of capt

Kidney Diseases [SEP] Pathological processes of the KIDNEY or its component tissues.


proteinuria [SEP] ation of captopril at 100 mg/kg for 14 days failed to aggravate proteinuria pre-existing in SHR. Also, captopril treatment failed to potent


puromycin aminonucleoside [SEP] ate or facilitate development of massive proteinuria invoked by puromycin aminonucleoside in SHR. Captopril had little or no demonstrable effects on seru


Captopril [SEP] assive proteinuria invoked by puromycin aminonucleoside in SHR. Captopril had little or no demonstrable effects on serum electrolyte conc


sodium [SEP] ffects on serum electrolyte concentrations, excretion of urine, sodium and potassium, endogenous creatinine clearance, body weight, an

Sodium [SEP] A member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23.


potassium [SEP] erum electrolyte concentrations, excretion of urine, sodium and potassium, endogenous creatinine clearance, body weight, and food and wat

Potassium [SEP] An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cat


creatinine [SEP] ntrations, excretion of urine, sodium and potassium, endogenous creatinine clearance, body weight, and food and water consumption. However

Creatinine [SEP]


ketone [SEP] learance, body weight, and food and water consumption. However, ketone bodies were consistently present in urine and several lethaliti

Ketones [SEP]


enflurane [SEP] Epileptogenic properties of enflurane and their clinical interpretation.

Enflurane [SEP] An extremely stable inhalation anesthetic that allows rapid adjustments of anesthesia depth with little change in pulse or respi


enflurane [SEP] Three cases of EEG changes induced by single exposure to enflurane anesthesia are reported. In one patient, enflurane administered


seizures [SEP] during a donor nephrectomy resulted in unexpected partial motor seizures. Until the cause of the seizures was correctly identified, the

Seizures [SEP] Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of br


Epileptic [SEP] l, complex and generalized seizures uncontrolled by medication. Epileptic foci delineated and activated by enflurane were surgically abla

Epilepsy [SEP] A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuron


seizure [SEP] during a donor nephrectomy resulted in unexpected partial motor seizures. Until the cause of the seizures was correctly identified, the


epileptic [SEP] hand, enflurane may prove to be a safe fast acting activator of epileptic foci during corticography or depth electrode intraoperative rec


cerebral lesions [SEP] Reversible cerebral lesions associated with tiazofurin usage: MR demonstration.

Brain Diseases [SEP] Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This


tiazofurin [SEP] Reversible cerebral lesions associated with tiazofurin usage: MR demonstration.

tiazofurin [SEP]


Tiazofurin [SEP] Tiazofurin is an experimental chemotherapeutic agent currently undergoing

tiazofurin [SEP]


cerebral abnormalities [SEP] esults with magnetic resonance (MR) in demonstrating reversible cerebral abnormalities concurrent with the use of this drug. The abnormalities on MR w


diazepam [SEP] Antagonism of diazepam-induced sedative effects by Ro15-1788 in patients after surgery

Diazepam [SEP] A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of actio


Ro15-1788 [SEP] Antagonism of diazepam-induced sedative effects by Ro15-1788 in patients after surgery under lumbar epidural block. A double

Flumazenil [SEP] A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been su


Ro15-1788 [SEP] The aim of this study was to assess the efficacy of Ro15-1788 and a placebo in reversing diazepam-induced effects after surge


diazepam [SEP]  to assess the efficacy of Ro15-1788 and a placebo in reversing diazepam-induced effects after surgery under epidural block, and to eval


amnesia [SEP] nt of mood rating, an objective test of performance, a test for amnesia, and vital signs were recorded for up to 300 min after administ

Amnesia [SEP] Pathologic partial or complete loss of the ability to recall past experiences (AMNESIA, RETROGRADE) or to form new memories (AMN


epinephrine [SEP] Enhanced stimulus-induced neurotransmitter overflow in epinephrine-induced hypertensive rats is not mediated by prejunctional beta

Epinephrine [SEP] The active sympathomimetic hormone from the ADRENAL MEDULLA. It stimulates both the alpha- and beta- adrenergic systems, causes


hypertensive [SEP] imulus-induced neurotransmitter overflow in epinephrine-induced hypertensive rats is not mediated by prejunctional beta-adrenoceptor activat


epinephrine [SEP] The present study examines the effect of 6-day epinephrine treatment (100 micrograms/kg per h, s.c.) on stimulus-induced (


catecholamine [SEP] perfused kidney of vehicle- and epinephrine-treated rats. Renal catecholamine stores and stimulus-induced overflow in the vehicle-treated gro

Catecholamines [SEP] A general class of ortho-dihydroxyphenylalkylamines derived from tyrosine.


norepinephrine [SEP] ulus-induced overflow in the vehicle-treated group consisted of norepinephrine only. However, epinephrine treatment resulted in the incorporat

Norepinephrine [SEP] Precursor of epinephrine that is secreted by the adrenal medulla and is a widespread central and autonomic neurotransmitter. Nor


Propranolol [SEP] was not affected by neuronal and extraneuronal uptake blockade. Propranolol had no effect on stimulus-induced overflow in either group. Phe

Propranolol [SEP] A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; A


Phentolamine [SEP] lol had no effect on stimulus-induced overflow in either group. Phentolamine increased stimulus-induced overflow in both groups although the

Phentolamine [SEP] A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromo


phentolamine [SEP] esponsible for this alteration. Furthermore, data obtained with phentolamine alone do not suggest alpha-adrenoceptor desensitization as the


juvenile rheumatoid arthritis [SEP] Ocular manifestations of juvenile rheumatoid arthritis.

Arthritis, Juvenile [SEP] Arthritis of children, with onset before 16 years of age. The terms juvenile rheumatoid arthritis (JRA) and juvenile idiopathic


juvenile rheumatoid arthritis [SEP] We followed 210 cases of juvenile rheumatoid arthritis closely for eleven years. Thirty-six of the 210 patients (17.2%


iridocyclitis [SEP]  eleven years. Thirty-six of the 210 patients (17.2%) developed iridocyclitis. Iridocyclitis was seen most frequently in young female patient

Iridocyclitis [SEP] Acute or chronic inflammation of the iris and ciliary body characterized by exudates into the anterior chamber, discoloration of


Iridocyclitis [SEP] Thirty-six of the 210 patients (17.2%) developed iridocyclitis. Iridocyclitis was seen most frequently in young female patients (0 to 4 years


arthritis [SEP] We followed 210 cases of juvenile rheumatoid arthritis closely for eleven years. Thirty-six of the 210 patients (17.2%

Arthritis [SEP]


uveitis [SEP] r form of the arthritis. However, 30% of the patients developed uveitis after 16 years of age. Although 61% of patients had a noncontri

Uveitis [SEP] Inflammation of part or all of the uvea, the middle (vascular) tunic of the eye, and commonly involving the other tunics (sclera


ocular pain [SEP] ad one or more identifiable signs or symptoms, such as red eye, ocular pain, decreased visual acuity, or photophobia, in order of decreasin

Eye Pain [SEP] A dull or sharp painful sensation associated with the outer or inner structures of the eyeball, having different causes.


decreased visual acuity [SEP] e identifiable signs or symptoms, such as red eye, ocular pain, decreased visual acuity, or photophobia, in order of decreasing frequency. Even after e

Vision Disorders [SEP] Visual impairments limiting one or more of the basic functions of the eye: visual acuity, dark adaptation, color vision, or peri


photophobia [SEP] toms, such as red eye, ocular pain, decreased visual acuity, or photophobia, in order of decreasing frequency. Even after early detection a

Photophobia [SEP] Abnormal sensitivity to light. This may occur as a manifestation of EYE DISEASES; MIGRAINE; SUBARACHNOID HEMORRHAGE; MENINGITIS;


corticosteroids [SEP] ond to more than six months of intensive topical treatment with corticosteroids and mydriatics. Despite this, there was a dramatic decrease in

Adrenal Cortex Hormones [SEP]


Cataract [SEP]  of blinding complications of uveitis cited in earlier studies. Cataract and band keratopathy occurred in only 22 and 13% of our group,

Cataract [SEP] Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many ki


band keratopathy [SEP] complications of uveitis cited in earlier studies. Cataract and band keratopathy occurred in only 22 and 13% of our group, respectively. We used

Corneal Dystrophy, Band-Shaped [SEP]


chloroquine [SEP] occurred in only 22 and 13% of our group, respectively. We used chloroquine or hydroxychloroquine in 173 of 210 cases and found only one ca

Chloroquine [SEP] The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arth


hydroxychloroquine [SEP] y 22 and 13% of our group, respectively. We used chloroquine or hydroxychloroquine in 173 of 210 cases and found only one case of chorioretinopath

Hydroxychloroquine [SEP] A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate i


chorioretinopathy [SEP] droxychloroquine in 173 of 210 cases and found only one case of chorioretinopathy attributable to these drugs. Systemically administered corticos

Retinal Diseases [SEP]


cataracts [SEP]  75 of 210 cases; a significant number of posterior subcapsular cataracts was found. Typical keratoconjunctivitis sicca developed in thre


keratoconjunctivitis [SEP] nt number of posterior subcapsular cataracts was found. Typical keratoconjunctivitis sicca developed in three of the uveitis cases. This association

Keratoconjunctivitis [SEP] Simultaneous inflammation of the cornea and conjunctiva.


glaucoma [SEP] viously. Surgical treatment of cataracts, band keratopathy, and glaucoma achieved uniformly discouraging results.

Glaucoma [SEP] An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the int


Water intoxication [SEP] Water intoxication associated with oxytocin administration during saline-induced a

Water Intoxication [SEP] A condition resulting from the excessive retention of water with sodium depletion.


oxytocin [SEP] Water intoxication associated with oxytocin administration during saline-induced abortion.

Oxytocin [SEP] A nonapeptide hormone released from the neurohypophysis (PITUITARY GLAND, POSTERIOR). It differs from VASOPRESSIN by two amino a


abortion [SEP] n associated with oxytocin administration during saline-induced abortion.

Abortion, Septic [SEP] Any type of abortion, induced or spontaneous, that is associated with infection of the UTERUS and its appendages. It is characte


water intoxication [SEP] Four cases of water intoxication in connection with oxytocin administration during saline-induce


oxytocin [SEP] Four cases of water intoxication in connection with oxytocin administration during saline-induced abortions are described. T


abortions [SEP] n connection with oxytocin administration during saline-induced abortions are described. The mechanism of water intoxication is discussed


Oxytocin [SEP] sm of water intoxication is discussed in regard to these cases. Oxytocin administration during midtrimester-induced abortions is advocat


asthenia [SEP] tch the diuresis and report such early signs of the syndrome as asthenia, muscular irritability, or headaches. The oxytocin should be gi

Asthenia [SEP] Clinical sign or symptom manifested as debility, or lack or loss of strength and energy.


irritability [SEP] d report such early signs of the syndrome as asthenia, muscular irritability, or headaches. The oxytocin should be given only in Ringers lac

Mental Disorders [SEP] Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of tho


headaches [SEP] ly signs of the syndrome as asthenia, muscular irritability, or headaches. The oxytocin should be given only in Ringers lactate or, alter

Headache [SEP] The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACH


lactate [SEP] ity, or headaches. The oxytocin should be given only in Ringers lactate or, alternately, in Ringers lactate and a 5 per cent dextrose a

Lactic Acid [SEP] A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent


dextrose [SEP] rs lactate or, alternately, in Ringers lactate and a 5 per cent dextrose and water solutions. The urinary output should be monitored and

Glucose [SEP] A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in i